Seta Noriyuki, Tajima Michiko, Kobayashi Shigeto, Kawakami Yutaka, Hashimoto Hiroshi, Kuwana Masataka
Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Mod Rheumatol. 2008;18(6):593-600. doi: 10.1007/s10165-008-0109-1. Epub 2008 Sep 18.
The aim of this study was to evaluate the characteristics of autoreactive T cells to myeloperoxidase (MPO) in patients with MPO-antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Peripheral blood T cells from 15 patients with MPO-ANCA-associated vasculitis and 14 healthy individuals were cultured with three recombinant proteins that together comprised the entire MPO sequence (L, all 112 amino acids (AA) of the light chain; HI, AA 1-227 of the heavy chain; HII, AA 212-467 of the heavy chain), and the antigen-specific T-cell proliferative response was measured by 3H-thymidine incorporation. T-cell responses to MPO-L and HI were both detected in four patients and three healthy donors, and responses to MPO-HII were detected in four patients and seven healthy donors. These findings indicate that at least three independent T-cell epitopes exist on the MPO molecule. Interestingly, the patients whose T cells showed these MPO-induced responses were mainly in remission. Peripheral blood T cells reactive with MPO were primarily of the HLA-DR-restricted CD4+ phenotype. In summary, we successfully used recombinant MPO fragments to detect autoreactive CD4+ T cells to multiple MPO epitopes in blood samples from patients with MPO-ANCA-associated vasculitis and healthy individuals.
本研究的目的是评估髓过氧化物酶(MPO)-抗中性粒细胞胞浆抗体(ANCA)相关血管炎患者中针对MPO的自身反应性T细胞的特征。将15例MPO-ANCA相关血管炎患者和14名健康个体的外周血T细胞与三种重组蛋白共同培养,这三种重组蛋白共同构成了完整的MPO序列(L,轻链的全部112个氨基酸(AA);HI,重链的第1-227个AA;HII,重链的第212-467个AA),并通过3H-胸腺嘧啶核苷掺入法测量抗原特异性T细胞增殖反应。在4例患者和3名健康供者中均检测到对MPO-L和HI的T细胞反应,在4例患者和7名健康供者中检测到对MPO-HII的反应。这些发现表明MPO分子上至少存在三个独立的T细胞表位。有趣的是,其T细胞显示出这些MPO诱导反应的患者主要处于缓解期。与MPO反应的外周血T细胞主要是HLA-DR限制的CD4+表型。总之,我们成功地使用重组MPO片段检测了MPO-ANCA相关血管炎患者和健康个体血样中针对多个MPO表位的自身反应性CD4+T细胞。